We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Stem Cells Cultured in Human In Vitro System

By Biotechdaily staff writers
Posted on 02 Apr 2003
A recent study describes the use of human marrow stromal cells to replace mouse embryonic fibroblasts as feeder cells for the in vitro cultivation of human embryonic stem cells. More...
The study appeared in the March 2003 issue of Stem Cells.

Investigators at Johns Hopkins University (Baltimore, MD, USA) have been seeking alternative methods for maintaining cultures of primitive, undifferentiated human embryonic stem cells in order to avoid use of growth factors of rodent origin. They used culture-expanded human marrow stromal cells from multiple donors as feeder cells to support growth of a human embryonic stem cell line under serum-free culture conditions. Stem cell colonies cultured on irradiated stromal cells amplified more than 100-fold during 30 days of continuous culture (in five passages). The longest continuous expansion of stem cells on stromal cells tested to date was 13 passages.

"After eight months of dividing under these conditions, the human embryonic stem cells still look and act just like the originals,” explained first author Dr. Linzhao Cheng, assistant professor of oncology at the Johns Hopkins University's Kimmel Cancer Center. "Marrow stromal cells co-exist cells with blood-forming stem cells in bone marrow and support their growth in the lab, but we were surprised they could fully replace mouse cells in supporting more primitive embryonic stem cells. When it is time to create new stem cell lines, this issue will be very important. Our results together with those of others show that it should be possible to establish new stem cell lines without using mouse cells or proteins.”



Related Links:
Johns Hopkins University

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
Procalcitonin Test
LIAISON B•R•A•H•M•S PCT II GEN
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.